Two companies have applied to the FDA to start clinical trials.\ in late 2019 or early 2020. ActoBio Theraputics just received FDA approval to begin clinical trials on their new drug AG017 in Phase 1b/2a in the US and Europe later this year. They will enroll 42 patients. AG017 is an oral medication. It involves … Continue reading Two New Drug Entering Trials Soon
Stem cells can cure Refractory Celiac Type 2 - but that is celiac you don't want!
I've talked about AMG 714 in the past. Here's the first article about AMG I wrote a few months ago. Now, it seems there will be results from the initial trial of AMG 714 with two people with Refractory Celiac Disease Type 2.
Nexvax: One Month Later - So, its been about a month since I was removed from the Nexvaxx trial for my safety. Just in case you didn't know, a day after food challenge #2 I had an allergic reaction that required me to go to the ER to get it under control. I'm fine, but out of an abundance of caution I was removed from the study. Fair enough.
Tales of wrapping up in Nashville
Promise of a cure by 2021!